Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial-Reference-Cited by-同舟云学术

Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial

Published:2020-04 Issue:10232 Volume:395 Page:1268-1277
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Birtle Alison,Johnson Mark,Chester John,Jones Robert,Dolling David,Bryan Richard T,Harris Christopher,Winterbottom Andrew,Blacker Anthony,Catto James W F,Chakraborti Prabir,Donovan Jenny L,Elliott Paul Anthony,French Ann,Jagdev Satinder,Jenkins Benjamin,Keeley Francis Xavier,Kockelbergh Roger,Powles Thomas,Wagstaff John,Wilson Caroline,Todd Rachel,Lewis Rebecca,Hall Emma

Funder

Cancer Research UK

ICR-CTSU

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update;Roupret;Eur Urol,2018

2. The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC);Audenet;Urol Oncol,2013

3. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial;J Clin Oncol,2011

4. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study;Loehrer;J Clin Oncol,1992

5. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial;Sternberg;Lancet Oncol,2015

Cited by 356 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological risk factors associated with tumor relapse of upper tract urothelial carcinoma after radical nephroureterectomy: A single institution 20-year experience;Annals of Diagnostic Pathology;2024-12

2. Perioperative renal function change and oncological outcomes of radical nephroureterectomy in patients with upper tract urothelial carcinoma: A multicenter retrospective study;Urologic Oncology: Seminars and Original Investigations;2024-10

3. Organerhaltende Therapien beim Urothelkarzinom des oberen Harntrakts;Die Urologie;2024-09-13

4. Das metastasierte und fortgeschrittene Urothelkarzinom des oberen Harntraktes – eigene Entität oder doch kleine Schwester des Blasenkarzinoms?;Die Urologie;2024-09-02

5. Survival outcomes by race following surgical treatment for upper tract urothelial carcinoma;Clinical Genitourinary Cancer;2024-09